244 related articles for article (PubMed ID: 20133630)
1. Disruption of the Lcn2 gene in mice suppresses primary mammary tumor formation but does not decrease lung metastasis.
Berger T; Cheung CC; Elia AJ; Mak TW
Proc Natl Acad Sci U S A; 2010 Feb; 107(7):2995-3000. PubMed ID: 20133630
[TBL] [Abstract][Full Text] [Related]
2. Caveolin-1 gene disruption promotes mammary tumorigenesis and dramatically enhances lung metastasis in vivo. Role of Cav-1 in cell invasiveness and matrix metalloproteinase (MMP-2/9) secretion.
Williams TM; Medina F; Badano I; Hazan RB; Hutchinson J; Muller WJ; Chopra NG; Scherer PE; Pestell RG; Lisanti MP
J Biol Chem; 2004 Dec; 279(49):51630-46. PubMed ID: 15355971
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of lipocalin 2 impairs breast tumorigenesis and metastasis.
Leng X; Ding T; Lin H; Wang Y; Hu L; Hu J; Feig B; Zhang W; Pusztai L; Symmans WF; Wu Y; Arlinghaus RB
Cancer Res; 2009 Nov; 69(22):8579-84. PubMed ID: 19887608
[TBL] [Abstract][Full Text] [Related]
4. Contributions of the RhoA guanine nucleotide exchange factor Net1 to polyoma middle T antigen-mediated mammary gland tumorigenesis and metastasis.
Zuo Y; Ulu A; Chang JT; Frost JA
Breast Cancer Res; 2018 May; 20(1):41. PubMed ID: 29769144
[TBL] [Abstract][Full Text] [Related]
5. No effect of NGAL/lipocalin-2 on aggressiveness of cancer in the MMTV-PyMT/FVB/N mouse model for breast cancer.
Cramer EP; Glenthøj A; Häger M; Juncker-Jensen A; Engelholm LH; Santoni-Rugiu E; Lund LR; Laerum OD; Cowland JB; Borregaard N
PLoS One; 2012; 7(6):e39646. PubMed ID: 22737251
[TBL] [Abstract][Full Text] [Related]
6. Pleiotropic functions of the tumor- and metastasis-suppressing matrix metalloproteinase-8 in mammary cancer in MMTV-PyMT transgenic mice.
Decock J; Hendrickx W; Thirkettle S; Gutiérrez-Fernández A; Robinson SD; Edwards DR
Breast Cancer Res; 2015 Mar; 17(1):38. PubMed ID: 25848906
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic induction of epithelial to mesenchymal transition by LCN2 mediates metastasis and tumorigenesis, which is abrogated by NF-κB inhibitor BRM270 in a xenograft model of lung adenocarcinoma.
Mongre RK; Sodhi SS; Sharma N; Ghosh M; Kim JH; Kim N; Park YH; Shin YG; Kim SJ; Jiao ZJ; Huynh do L; Jeong DK
Int J Oncol; 2016 Jan; 48(1):84-98. PubMed ID: 26573874
[TBL] [Abstract][Full Text] [Related]
8. Tumour stroma-derived lipocalin-2 promotes breast cancer metastasis.
Ören B; Urosevic J; Mertens C; Mora J; Guiu M; Gomis RR; Weigert A; Schmid T; Grein S; Brüne B; Jung M
J Pathol; 2016 Jul; 239(3):274-85. PubMed ID: 27038000
[TBL] [Abstract][Full Text] [Related]
9. Matrix metalloproteinase 13 is induced in fibroblasts in polyomavirus middle T antigen-driven mammary carcinoma without influencing tumor progression.
Nielsen BS; Egeblad M; Rank F; Askautrud HA; Pennington CJ; Pedersen TX; Christensen IJ; Edwards DR; Werb Z; Lund LR
PLoS One; 2008 Aug; 3(8):e2959. PubMed ID: 18698413
[TBL] [Abstract][Full Text] [Related]
10. Deletion of Cd151 reduces mammary tumorigenesis in the MMTV/PyMT mouse model.
Roselli S; Kahl RG; Copeland BT; Naylor MJ; Weidenhofer J; Muller WJ; Ashman LK
BMC Cancer; 2014 Jul; 14():509. PubMed ID: 25012362
[TBL] [Abstract][Full Text] [Related]
11. Anti-matrix metalloproteinase-9 DNAzyme decreases tumor growth in the MMTV-PyMT mouse model of breast cancer.
Hallett MA; Teng B; Hasegawa H; Schwab LP; Seagroves TN; Pourmotabbed T
Breast Cancer Res; 2013 Feb; 15(1):R12. PubMed ID: 23407024
[TBL] [Abstract][Full Text] [Related]
12. Lipocalin 2 promotes lung metastasis of murine breast cancer cells.
Shi H; Gu Y; Yang J; Xu L; Mi W; Yu W
J Exp Clin Cancer Res; 2008 Dec; 27(1):83. PubMed ID: 19077278
[TBL] [Abstract][Full Text] [Related]
13. The AIB1 oncogene promotes breast cancer metastasis by activation of PEA3-mediated matrix metalloproteinase 2 (MMP2) and MMP9 expression.
Qin L; Liao L; Redmond A; Young L; Yuan Y; Chen H; O'Malley BW; Xu J
Mol Cell Biol; 2008 Oct; 28(19):5937-50. PubMed ID: 18644862
[TBL] [Abstract][Full Text] [Related]
14. Metastasis is strongly reduced by the matrix metalloproteinase inhibitor Galardin in the MMTV-PymT transgenic breast cancer model.
Almholt K; Juncker-Jensen A; Laerum OD; Danø K; Johnsen M; Lund LR; Rømer J
Mol Cancer Ther; 2008 Sep; 7(9):2758-67. PubMed ID: 18790756
[TBL] [Abstract][Full Text] [Related]
15. Adipose monocyte chemotactic protein-1 deficiency reduces high-fat diet-enhanced mammary tumorigenesis in MMTV-PyMT mice.
Sundaram S; Yan L
J Nutr Biochem; 2020 Mar; 77():108313. PubMed ID: 31837540
[TBL] [Abstract][Full Text] [Related]
16. Disruption of the SRC-1 gene in mice suppresses breast cancer metastasis without affecting primary tumor formation.
Wang S; Yuan Y; Liao L; Kuang SQ; Tien JC; O'Malley BW; Xu J
Proc Natl Acad Sci U S A; 2009 Jan; 106(1):151-6. PubMed ID: 19109434
[TBL] [Abstract][Full Text] [Related]
17. Haploinsufficiency in the prometastasis Kiss1 receptor Gpr54 delays breast tumor initiation, progression, and lung metastasis.
Cho SG; Wang Y; Rodriguez M; Tan K; Zhang W; Luo J; Li D; Liu M
Cancer Res; 2011 Oct; 71(20):6535-46. PubMed ID: 21852382
[TBL] [Abstract][Full Text] [Related]
18. Frequent overexpression of AMAP1, an Arf6 effector in cell invasion, is characteristic of the MMTV-PyMT rather than the MMTV-Neu human breast cancer model.
Otsuka Y; Oikawa T; Yoshino H; Hashimoto S; Handa H; Yamamoto H; Hashimoto A; Sabe H
Cell Commun Signal; 2018 Jan; 16(1):1. PubMed ID: 29329590
[TBL] [Abstract][Full Text] [Related]
19. Mammary tumor growth and metastasis are reduced in c-Kit mutant Sash mice.
He L; Zhu Z; Chen S; Wang Y; Gu H
Cancer Med; 2016 Jun; 5(6):1292-7. PubMed ID: 26992445
[TBL] [Abstract][Full Text] [Related]
20. Chemoprevention activity of dipyridamole in the MMTV-PyMT transgenic mouse model of breast cancer.
Wang C; Schwab LP; Fan M; Seagroves TN; Buolamwini JK
Cancer Prev Res (Phila); 2013 May; 6(5):437-47. PubMed ID: 23447563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
